Read More

Jim Cramer Advises Investors To Stick With Good Companies Despite Short-Term Losses: ‘You Just Need To Figure Out Which Companies Deserve Your Confidence’

Cramer, a prominent figure in the finance world, suggested that investors should not emulate the trading habits of large hedge funds. Instead, he recommended a long-term investment strategy, emphasizing the need to anticipate and endure market declines.

AAPL

Read More

Trump’s China Tariff Hikes Could Smother US Economic Growth: Fitch Ratings Sounds Alarm

Fitch Ratings warns of economic fallout from Trump's proposed trade tariffs if he wins 2020 election. US GDP could decline by 0.4-1.1%, and inflation may decrease in long term. US trading partners could see even greater declines, with China, Canada, and Mexico at risk. Trade imbalance blamed on savings and investment disparity, not tariffs.

GXC

Read More

Analysts’ Varied Perspectives On CytomX’s CX-904 Cancer Study: Safety Profile But Caution in Pancreatic Cancer

Initial data from CytomX Therapeutics' CX-904 Phase 1a study shows safety and anti-cancer activity in heavily pretreated patients with advanced metastatic solid tumors. Reductions observed, especially in pancreatic cancer, with stable disease maintained.

CTMX